Quality Metrics Could Spur Drug GMPs Compliance, But Pose Risks
This article was originally published in The Tan Sheet
Executive Summary
FDA hopes development of a quality metrics initiative will help clarify drug good manufacturing practice requirements and improve the agency’s inspections and enforcement. Industry supports using metrics as a tool, but warns they could pose unintentional risks if implemented incorrectly.